ScientiaCME One team, one plan: multidisciplinary, culturally considerate, shared care for people living with HIV
In this online, self-learning activity:
Human immunodeficiency virus (HIV) is a retrovirus that preferentially targets CD4+ T lymphocytes, driving chronic immune activation, CD4+ depletion, and heightened vulnerability of people living with it (PLWH) to opportunistic infections and certain malignancies. Early, guideline-concordant primary care engagement is essential to mitigate these risks and optimize long-term outcomes. Contemporary antiretroviral therapy (ART) recommendations from major panels provide multiple highly effective, well-tolerated options that enable durable viral suppression when initiated promptly and supported over time.
Cost: Free
View Offer chevron_rightDetails
In this online, self-learning activity:
Human immunodeficiency virus (HIV) is a retrovirus that preferentially targets CD4+ T lymphocytes, driving chronic immune activation, CD4+ depletion, and heightened vulnerability of people living with it (PLWH) to opportunistic infections and certain malignancies. Early, guideline-concordant primary care engagement is essential to mitigate these risks and optimize long-term outcomes. Contemporary antiretroviral therapy (ART) recommendations from major panels provide multiple highly effective, well-tolerated options that enable durable viral suppression when initiated promptly and supported over time.
Learning Objectives
By the end of the session the participant will be able to:
- Identify trends and epidemiology of HIV in the United States.
- Describe current diagnostic algorithms and baseline assessments for HIV infection.
- Select and individualize first-line treatment and switch antiretroviral therapy (ART) based on efficacy, resistance, comorbidities, and implementation factors.
- Discuss the role of and strategies for cardiometabolic and hepatic risk mitigation into longitudinal HIV care.
- Recall the impact of multidisciplinary models and shared-decision making on HIV patient care.
Target Audience
HCPs including but not limited to: infectious diseases, HIV, and internal medicine; physician assistants, nurse practitioners, and pharmacists who practice in infectious disease; and any other HCPs with an interest in or who clinically encounter patients with HIV.
Additional credit info
ScientiaCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: ScientiaCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ toward the AMA Physician’s Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ABIM MOC Credit Type: Medical Knowledge
Physicians: For maintenance of certification (MOC) points, you must enter your board certification ID # and birth date correctly. It is the learner’s responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive MOC points for this activity. By providing this data, you acknowledge that it will be shared with ACCME and the applicable certifying board. Please note: Not all activities on this site provide MOC points. If this activity does not specify that it provides MOC points in this section, then it does NOT provide MOC points. This activity provides MOC points only for ABIM.
Pharmacists
ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE #0574-0000-26-007-H01-P. This is an Application (A)-type activity.

Pharmacists: You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner’s responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.
Nurses: This activity is designated for up to 1.0 AMA PRA Category 1 Credit(s)™, and the American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit(s)™ to meet the continuing education renewal requirements of nursing re-certification for APRNs and RN specialty. Some state nursing boards accept AMA PRA Category 1 Credit(s)™ for re-licensure requirements, some do not. Check your state board of nursing’s CE requirements before applying credit from this course to your re-licensure.
Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit™ assigned by organizations accredited by the ACCME as satisfying Category 1 CME for National Commission on Certification of Physician Assistants (NCCPA) national certification maintenance. This activity is designated for up to 1.0 AMA PRA Category 1 Credit(s)™.
Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCB) states that continuing education providers accredited by the ACCME may provide acceptable, accredited Advanced Practice Provider content. This activity is designated for up to 1.0 AMA PRA Category 1 Credit(s)™.